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Multiple saccular aneurysms in a young woman
Masashi Kawamura, MD, Hitoshi Ogino, MD, Hiroaki Sasaki, MD, Hatsue Ishibashi-Ueda, MD, andSoichiro Kitamura, MD, Osaka, JapanOn medical examination, the chest radiograph of a 25-year-old healthy woman
incidentally revealed an abnormal shadow. Enhanced computed tomography
(CT) revealed three saccular aneurysms, and the patient was referred for surgical
treatment.
Physical examination did not yield any particular findings. Three-dimensional
CT showed that two of the aneurysms were located at the proximal descending
aorta (cover). The larger aneurysmwas 45mm in diameter, and the smaller was 35
mm in diameter. The third aneurysm was located at the proximal part of the left
subclavian artery, and it was 12mm in diameter (cover). Thinning of the aorta and
artery was also observed (A), but no other complications in the cardiovascular
system were detected. Surgical treatment was performed. The aneurysms were
exposed by a left thoracotomy via the fourth intercostal space (B). Graft replace-
ment of the proximal descending aorta with reconstruction of the left subclavian
artery was performed under deep hypothermic circulatory arrest. The blood
vessels were very fragile and difficult to anastomose. Postoperative recovery was
uneventful. The histopathological specimens of the resected aneurysms indicated
severe cystic medial necrosis (elastic van Gieson stain, 40; C).
Marfan syndrome and Ehlers-Danlos syndrome type IV (the vascular type) are
well-known disorders characterized by the occurrence of aortic aneurysm or
dissection at an early age. Molecular analyses of these syndromes have recently
advanced. Mutations in the genes encoding fibrillin-1 and transforming growth
factor beta receptor 1 and 2 have been shown in Marfan syndrome,1 and
mutations in the gene encoding type III procollagen have been identified in
Ehlers-Danlos syndrome type IV.2 In our patient, genetic testing for these genes
was carried out, but it yielded negative results. Other cardiovascular disorders are
expected to occur in this patient, and therefore, careful and lifelong follow-up is
required.
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